NEWARK, Del., March 11, 2025 /PRNewswire/ — OpenSSL Corporation announces that OpenSSL 3.1.2 has achieved FIPS 140-3 validation, meeting the latest cryptographic security standards set by National Institute of Standards and Technology (NIST). This certification strengthens OpenSSL Library’s role in securing government, financial, and healthcare sectors.
The OpenSSL 3.1.2 FIPS Provider has been officially listed under Certificate #4985, valid for five years until March 10, 2030. This certification ensures that organizations leveraging OpenSSL for secure communications, data protection, and compliance-driven encryption can do so with confidence.
Key Features & Enhancements:
Benefits of FIPS 140-3 Compliance:
Leadership Insight
Tim Hudson, President of OpenSSL Corporation, stated: “With OpenSSL 3.1.2 achieving FIPS 140-3 validation, organizations can now confidently deploy a certified cryptographic module that meets the latest security standards. To ensure a smooth transition, we encourage businesses to review their existing deployments, leverage OpenSSL Library’s comprehensive documentation, and engage our technical support for seamless integration. Our FIPS rebranding services also offer enterprises the flexibility to obtain validation under their own branding, simplifying regulatory compliance and accelerating secure adoption.”
A Word of Appreciation
The OpenSSL Corporation extends its gratitude to NIST CMVP and the broader OpenSSL community for their contributions. This milestone reinforces OpenSSL Corporation’s commitment to delivering trusted cryptographic solutions that power secure communications worldwide.
More Information
Contact:
OpenSSL Corporation
corporation@openssl.org
Photo(s):
https://www.prlog.org/13065950
Press release distributed by PRLog
SOURCE OpenSSL Corporation
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…